PGA
BIIB icon

Premia Global Advisors’s Biogen BIIB Stock Holding History

Premia Global Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-95
Closed -$22K – 94
2019
Q1 		$22K Buy
+95
New +$29.9K 0.02% 285
2018
Q2 		– Sell
-138
Closed -$37K – 207
2018
Q1 		$37K Buy
138
+13
+10% +$4.04K 0.03% 227
2017
Q4 		$39K Buy
+125
New +$40.1K 0.04% 224

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Premia Global Advisors's BIIB Position: Q2 2019 in Review

Premia Global Advisors sold out of Biogen (BIIB) in Q2 2019, closing a stake of 95 shares — an estimated $22K sold.

Premia Global Advisors first reported a position in BIIB in Q4 2017 and held it in 3 quarters. The position peaked at $39K in Q4 2017. 1,010 funds tracked by Wall St. Rank hold BIIB as of Q2 2019.

  • Premia Global Advisors reported no remaining Biogen position as of Q2 2019 after selling out during the quarter.
  • Premia Global Advisors sold 95 Biogen shares in Q2 2019, an estimated $22K.
  • Premia Global Advisors first reported a position in Biogen in Q4 2017 and held it in 3 quarters.
  • Premia Global Advisors's Biogen position peaked at $39K in Q4 2017.
  • 1,010 funds tracked by Wall St. Rank held Biogen as of Q2 2019.

Based on Premia Global Advisors's 13F filing for Q2 2019, filed 13 Aug 2019.